Liver Tumors Clinical Trial
Official title:
Communicating Veins Between Adjacent Hepatic Veins: Rare, Exceptional or Frequent? An Intra-operative Ultrasound Study
The search for communicating veins (CVs) between adjacent hepatic veins (HVs) has drawn its
rationale from living donor liver transplantation (LDLT). Parenchymal sparing procedures
although HVs are resected suggest that probably their presence is underestimated.
Taking profit from new improvements in ultrasound technology the investigators aim to better
estimate the rate of CVs in a consecutive series of patients in whom resection of one HV at
caval confluence is needed.
The search for communicating veins (CVs) between adjacent hepatic veins (HVs) has drawn its
rationale from the need of reducing the risk of incomplete blood outflow in the medial
portion of the hemiliver without the middle hepatic vein (MHV) in living donor liver
transplantation (LDLT). However, only 24% of patients seems having CVs based on the findings
of color-Doppler intraoperative ultrasound (CD-IOUS) exploration. On the other hand the
safety of parenchymal sparing procedure despite HV resection let suppose that CVs are
probably more frequent than expected.
Certainly, better in vivo knowledge of the rate of CVs and their direct detection would
consolidate and probably further expand parenchymal sparing techniques. Taking profit from
new advancements in ultrasound technology we have carried out the present study with the aim
of better estimating the rate of CVs in a consecutive series of patients in whom resection
of one HV at caval confluence was needed.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01197820 -
Hepatic and Renal Thermography Using Magnetic Resonance Imaging
|
N/A | |
| Terminated |
NCT00942383 -
Freehand Ultrasound Elasticity Imaging in Liver Surgery
|
||
| Completed |
NCT01782573 -
The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients
|
Phase 4 | |
| Active, not recruiting |
NCT03432806 -
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
|
||
| Completed |
NCT01403727 -
Electromagnetic Tracking of Devices During Biopsy Procedures
|
N/A | |
| Recruiting |
NCT00691691 -
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
|
Phase 2 | |
| Terminated |
NCT00955097 -
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
|
Phase 1 | |
| Recruiting |
NCT02184182 -
Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)
|
Phase 2 | |
| Completed |
NCT02162732 -
Molecular-Guided Therapy for Childhood Cancer
|
N/A | |
| Recruiting |
NCT05990257 -
CMRA for US-guided-MWA of Liver Tumors
|
N/A | |
| Completed |
NCT00828607 -
Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses
|
N/A | |
| Completed |
NCT05445973 -
Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation
|
N/A | |
| Completed |
NCT03171428 -
Hepatectomy With or Without the Thoraco-abdominal Approach
|
N/A | |
| Completed |
NCT02509507 -
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611
|
Phase 1/Phase 2 | |
| Completed |
NCT00877136 -
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
|
||
| Terminated |
NCT04315883 -
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
|
||
| Completed |
NCT01031784 -
Radioactive Holmium Microspheres for the Treatment of Liver Metastases
|
Phase 1 | |
| Active, not recruiting |
NCT00845689 -
Prevention of Liver Damage During Liver Surgery
|
Phase 1/Phase 2 |